Pulmonary Complications in Survivors of Childhood Hematological Malignancies: Single-Center Experience

REFERENCES

• Hudson MM. Survivors of childhood cancer: coming of age. Hematol Oncol Clin North Am. 2008;22:211–231, v–vi.
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, Cancer statistics. CA Cancer J Clin. 2008;58:71–96.
   PubMed Web of Science ®Google Scholar
• Guilcher GM, Fitzgerald C, Pritchard S. A questionnaire based review of long-term follow-up programs for survivors of childhood cancer in Canada. Pediatr Blood Cancer. 2009;52:113–115
   PubMed Web of Science ®Google Scholar
• Yeh JM, Nekhlyudov L, Goldie SJ, A model-based estimate of cumulative excess mortality in survivors of childhood cancer. Ann Intern Med. 2010;152:409–417, W131–W138.
   PubMed Web of Science ®Google Scholar
• Landau DA, Azaria B, Fineman R, Long-term survivors of childhood malignancies—aeromedical dilemmas and implications. Aviat Space Environ Med. 2006;77: 1266–1270.
   PubMedGoogle Scholar
• Gower WA, Collaco JM, Mogayzel PJ Jr. Lung function and late pulmonary complications among survivors of hematopoietic stem cell transplantation during childhood. Paediatr Respir Rev. 2010;11:115–122.
   PubMed Web of Science ®Google Scholar
• Von der Weid NX. Adult life after surviving lymphoma in childhood. Support Care Cancer. 2008;16:339–345.
   PubMed Web of Science ®Google Scholar
• Fulgoni P, Zoia MC, Corsico A, Lung function in survivors of childhood acute lymphoblastic leukemia. Chest. 1999;116:1163–1167.
   PubMed Web of Science ®Google Scholar
• Landier W, Bhatia S. Cancer survivorship: a pediatric perspective. Oncologist. 2008;13:1181–1192.
   PubMed Web of Science ®Google Scholar
• Schrappe M, Reiter A, Ludwig WD, Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood. 2000;95:3310–3322.
   PubMed Web of Science ®Google Scholar
• Ravindranath Y, Chang M, Steuber CP, Pediatric Oncology Group.Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia. 2005;19:2101–2116.
   PubMed Web of Science ®Google Scholar
• Johnson PW, Radford JA, Cullen MH, United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519). Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519). J Clin Oncol. 2005;23:9208–9218.
   PubMed Web of Science ®Google Scholar
• Reiter A, Schrappe M, Tiemann M, Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood. 1999;94:3294–3306.
   PubMed Web of Science ®Google Scholar
• Seidemann K, Tiemann M, Schrappe M, Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood. 2001;97:3699–3706.
   PubMed Web of Science ®Google Scholar
• Reiter A, Schrappe M, Ludwig WD, Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood. 2000;95:416–421.
   PubMed Web of Science ®Google Scholar
• Dimopoulou I, Efstathiou E, Samakovli A, A prospective study on lung toxicity in patients treated with gemcitabine and carboplatin: clinical, radiological and functional assessment. Ann Oncol. 2004;15:1250–1255.
   PubMed Web of Science ®Google Scholar
• Smith HJ, Reinhold P, Goldman MD. Forced oscillation technique and impulse oscillometry. Eur Respir Mon. 2005;31:72–105.
   Google Scholar
• Ganong WF. Review of Medical Physiology. New York: McGraw-Hill; 2001:655.
   Google Scholar
• Delacourt C, Lorino H, Herve -C, Use of forced oscillation technique to assess airway obstruction and reversibility in children. Am J Respir Crit Care Med. 2000;161:730–736.
   PubMed Web of Science ®Google Scholar
• Navajas D, Farré R. Oscillation mechanics. In: Milic-Emili J, ed. Respiratory Mechanics. Sheffield University European Respiratory Monographs. Vol. 4. Sheffield, UK: European Respiratory Society; 1999:112–140.
   Google Scholar
• Oguz A, Tayfun T, Citak EC, Long term pulmonary function in survivors of childhood Hodgkin disease and non Hodgkin disease. Pediatr Blood Cancer. 2007;49:699–703.
   PubMed Web of Science ®Google Scholar
• Nysom K, Holm K, Hertz H, Hesse B. Risk factors for reduced pulmonary function after malignant lymphoma in childhood. Med Pediatr Oncol. 1998;30:240–248.
   PubMedGoogle Scholar
• Liles A, Blatt J, Morris D, et al; Children's Oncology Group. Monitoring pulmonary complications in long-term childhood cancer survivors: guidelines for the primary care physician. Cleve Clin J Med. 2008;75:531–539.
   PubMed Web of Science ®Google Scholar
• Ilhan I, Sarialioglu F, Bilgic H, long term pulmonary function in children with Hodgkin disease. Acta Paediatr. 1996;85:324–326.
   PubMed Web of Science ®Google Scholar
• Hunger SP, Link MP, Donaldson SS. M ABVD/MOPP and low dose involve field radiotherapy in pediatric Hodgkin's disease: the Stanford experience. J Clin Oncol. 1994;12:1260–1266.
   Web of Science ®Google Scholar
• Jenney MEM, Faragher EB, Morris-Jopnes PH, Woudcock AA. Lung function and exercise capacity in survivors of childhood leukemia. Med Pediatr Oncol. 1995;24:222–230.
   PubMedGoogle Scholar
• Quanjer PH, Borsboom GJ, Brunekreef B, Spirometric reference values for white European children and adolescents: Polgar revisited. Pediatr Pulmonol. 1995;19:135–142.
   PubMed Web of Science ®Google Scholar
• Clausen JL, Coates AL, Quanjer PH. Measurement of lung volumes in humans: review and recommendations from an ATS/ERS workshop. Eur Respir J. 1997;10:1205–1206.
   PubMed Web of Science ®Google Scholar
• Doershuk CF, Fisher BJ, Matthews LW. Specific airway resistance from the perinatal period into adulthood. Alterations in childhood pulmonary disease. Am Rev Respir Dis. 1974;109:452–457.
   PubMedGoogle Scholar
• Polgar G, Weng TR. The functional development of the respiratory system from the period of gestation to adulthood. Am Rev Respir Dis. 1979;120:625–695.
   PubMed Web of Science ®Google Scholar
• Voltz JW, Card JW, Carey MA, Male sex hormones exacerbate lung function impairment after bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 2008;39:45–52.
   PubMed Web of Science ®Google Scholar
• Makipernaa A, Heino M, Laitinen LA, Siimes MA. Lung function following treatment of malignant tumor with surgery, radiotherapy, or cyclophosphamide in childhood. A follow up study after 11 to 27 years. Cancer. 1989;63:625–630.
   PubMed Web of Science ®Google Scholar
• Chawla A, Lavania AK. Air pollution and fuel vapour induced changes in lung functions: are fuel handlers safe? Indian J Physiol Pharmacol. 2008;52:255–261.
   PubMedGoogle Scholar
• Bossi G, Cerveri I, Volpini E, Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease. Ann Oncol. 1997;8(Suppl 1):19–24.
   PubMedGoogle Scholar
• Horning SJ, Adhikari A, Rizk N, Effect of treatment for Hodgkin disease on pulmonary function: results of a prospective study. J Clin Oncol. 1994;12:297–305.
   PubMed Web of Science ®Google Scholar
• Mertens AC, Yasui Y, Liu Y, et al; Childhood Cancer Survivor Study. Pulmonary complications in survivors of childhood and adolescent cancer. A report from the Childhood Cancer Survivor Study. Cancer. 2002;95:2431–2441.
   PubMed Web of Science ®Google Scholar
• Carver JR, Shapiro CL, Ng A, et al; ASCO Cancer Survivorship Expert Panel. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007;25:3991–4008.
   PubMed Web of Science ®Google Scholar
• Jenes BV, Carlesen NL, Groth S, Nissen NI. Late effects of pulmonary function of mantle field irradiation, chemotherapy or combined modality therapy for Hodgkin disease. Eur J Haematol. 1990;44:165–171.
   PubMed Web of Science ®Google Scholar
• Sleijfer S. Bleomycin-induced pneumonitis. Chest. 2001;120:617–624.
   PubMed Web of Science ®Google Scholar
• Azambuja E, Fleck JF, Batista RG, Menna Barreto SS. Bleomycin lung toxicity: who are the patients with increased risk? Pulm Pharmacol Ther. 2005;18:363–366.
   PubMed Web of Science ®Google Scholar
• Levi JA, Raghavan D, Harvey V, Australasian Germ Cell Trial Group. The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. J Clin Oncol. 1993;11:1300–1305.
   PubMed Web of Science ®Google Scholar
• Simpson AB, Paul J, Graham J, Kaye SB. Fatal bleomycin pulmonary toxicity in the west of Scotland 1991–95: a review of patients with germ cell tumours. Br J Cancer. 1998;78:1061–1066.
   PubMed Web of Science ®Google Scholar
• Dalgleish AG, Woods RL, Levi JA. Bleomycin pulmonary toxicity: its relationship to renal dysfunction. Med Pediatr Oncol. 1984;12:313–317.
   PubMedGoogle Scholar
• Kim YJ, Song M, Ryu JC. Mechanisms underlying methotrexate-induced pulmonary toxicity [review]. Expert Opin Drug Saf. 2009;8:451–458.
   PubMed Web of Science ®Google Scholar
• Tantawy AA, El-Bostany EA, Adly AA, Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia. Blood Coagul Fibrinolysis. 2010;21:28–34.
   PubMed Web of Science ®Google Scholar
• Rossi SE, Erasmus JJ, McAdams HP, Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics. 2000;20:1245–1259.
   PubMed Web of Science ®Google Scholar
• Cooper JA Jr, White DA, Matthay RA. Drug-induced pulmonary disease. 1. Cytotoxic drugs. Am Rev Respir Dis. 1986;133:321–340.
   PubMed Web of Science ®Google Scholar
• Sundgren PC. MR spectroscopy in radiation injury. Am Neuroradiol. 2009;30:1469–1476.
   PubMed Web of Science ®Google Scholar
• Tsapaki V. Radiation dose in interventional cardiology. Imaging Med. 2010;2:303–312.
   Google Scholar